Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Leukemia

  Free Subscription


01.11.2021

1 Acta Haematol
1 Am J Clin Pathol
3 Am J Hematol
4 Ann Hematol
1 Ann Oncol
4 Blood
1 BMC Cancer
1 Cancer Res
2 Eur J Haematol
3 Int J Hematol
3 J Pediatr Hematol Oncol
6 Leuk Lymphoma
4 Leuk Res
1 Leukemia
2 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acta Haematol

  1. TAKAHASHI S
    Kinase Inhibitors and Interferons as Other Myeloid Differentiation Inducers in Leukemia Therapy.
    Acta Haematol. 2021 Oct 21:1-9. doi: 10.1159/000519769.
    PubMed         Abstract available


    Am J Clin Pathol

  2. AQIL B, Gao J, Stalling M, Sukhanova M, et al
    Distinctive Flow Cytometric and Mutational Profile of Acute Myeloid Leukemia With t(8;16)(p11;p13) Translocation.
    Am J Clin Pathol. 2021 Oct 26. pii: 6410618. doi: 10.1093.
    PubMed         Abstract available


    Am J Hematol

  3. TROUSSARD X, Maitre E, Cornet E
    Hairy cell leukemia 2022: Update on diagnosis, risk-stratification, and treatment.
    Am J Hematol. 2021 Oct 28. doi: 10.1002/ajh.26390.
    PubMed         Abstract available

  4. MUCHTAR E, Koehler AB, Johnson MJ, Rabe KG, et al
    Humoral and cellular immune responses to recombinant herpes zoster vaccine in patients with chronic lymphocytic leukemia and monoclonal B cell lymphocytosis.
    Am J Hematol. 2021 Oct 26. doi: 10.1002/ajh.26388.
    PubMed         Abstract available

  5. ZHANG Y, Li X, Weng X, Shen Y, et al
    Optimization of idarubicin and cytarabine induction regimen with homoharringtonine for newly diagnosed acute myeloid leukemia patients based on the peripheral blast clearance rate: a single-arm, phase 2 trial (RJ-AML 2014).
    Am J Hematol. 2021 Oct 23. doi: 10.1002/ajh.26386.
    PubMed         Abstract available


    Ann Hematol

  6. REINERT J, Beitzen-Heineke A, Wethmar K, Stelljes M, et al
    Loss of CD22 expression and expansion of a CD22(dim) subpopulation in adults with relapsed/refractory B-lymphoblastic leukaemia after treatment with Inotuzumab-Ozogamicin.
    Ann Hematol. 2021;100:2727-2732.
    PubMed         Abstract available

  7. ARCANI R, Colle J, Cauchois R, Koubi M, et al
    Clinical characteristics and outcomes of patients with haematologic malignancies and COVID-19 suggest that prolonged SARS-CoV-2 carriage is an important issue.
    Ann Hematol. 2021;100:2799-2803.
    PubMed         Abstract available

  8. MENDES FR, da Silva WF, da Costa Bandeira de Melo R, Silveira DRA, et al
    Predictive factors associated with induction-related death in acute myeloid leukemia in a resource-constrained setting.
    Ann Hematol. 2021 Oct 21. pii: 10.1007/s00277-021-04687.
    PubMed         Abstract available

  9. STANGANELLI C, Torres DC, Ortega C, Marquez ME, et al
    Somatic hypermutation profiles in stereotyped IGHV4-34 receptors from South American chronic lymphocytic leukemia patients.
    Ann Hematol. 2021 Oct 28. pii: 10.1007/s00277-021-04703.
    PubMed         Abstract available


    Ann Oncol

  10. VAN GELDER M, Tournilhac O, Te Raa D, Visser HPJ, et al
    Front-line chemo-immunotherapy is not inferior to ibrutinib in CLL.
    Ann Oncol. 2021;32:1442-1443.
    PubMed        


    Blood

  11. ZHAO Y, Wang E
    Plasmablastic myeloma/leukemia variant of monomorphic posttransplant lymphoproliferative disorder.
    Blood. 2021;138:1510.
    PubMed        

  12. KOGURE Y, Kameda T, Koya J, Yoshimitsu M, et al
    Whole-genome landscape of adult T-cell leukemia/lymphoma.
    Blood. 2021 Oct 25. pii: S0006-4971(21)01784-5. doi: 10.1182/blood.2021013568.
    PubMed         Abstract available

  13. SCHNOEDER TM, Schwarzer A, Jayavelu AK, Hsu CJ, et al
    PLCG1 is required for AML1-ETO leukemia stem cell self-renewal.
    Blood. 2021 Oct 25. pii: S0006-4971(21)01783-3. doi: 10.1182/blood.2021012778.
    PubMed         Abstract available

  14. YASUDA T, Sanada M, Kawazu M, Kojima S, et al
    Two novel high-risk adult B-cell acute lymphoblastic leukemia subtypes with high expression of CDX2 and IDH1/2 mutations.
    Blood. 2021 Oct 25. pii: S0006-4971(21)01785-7. doi: 10.1182/blood.2021011921.
    PubMed         Abstract available


    BMC Cancer

  15. WILLIAMS MS, Basma NJ, Amaral FMR, Wiseman DH, et al
    Blast cells surviving acute myeloid leukemia induction therapy are in cycle with a signature of FOXM1 activity.
    BMC Cancer. 2021;21:1153.
    PubMed         Abstract available


    Cancer Res

  16. BIRAN A, Yin S, Kretzmer H, Ten Hacken E, et al
    Activation of Notch and Myc signaling via B cell-restricted depletion of Dnmt3a generates a consistent murine model of chronic lymphocytic leukemia.
    Cancer Res. 2021 Oct 22. pii: 0008-5472.CAN-21-1273.
    PubMed         Abstract available


    Eur J Haematol

  17. STEINGRIMSSON V, Lund SH, Dickman PW, Weibull CE, et al
    Survival, Causes of Death, and the Prognostic Role of Comorbidities in Chronic Lymphocytic Leukemia in the pre-ibrutinib era. A Population Based Study.
    Eur J Haematol. 2021 Oct 29. doi: 10.1111/ejh.13720.
    PubMed         Abstract available

  18. KOSCHADE SE, Stratmann JA, Miesbach W, Steffen B, et al
    Intracranial hemorrhage in newly diagnosed non-promyelocytic acute myeloid leukemia patients admitted for intensive induction chemotherapy.
    Eur J Haematol. 2021 Oct 29. doi: 10.1111/ejh.13718.
    PubMed         Abstract available


    Int J Hematol

  19. SHIBATA S, Inano S, Watanabe M, Fujiwara K, et al
    Identification of an asymptomatic Shwachman-Bodian-Diamond syndrome mutation in a patient with acute myeloid leukemia.
    Int J Hematol. 2021 Oct 26. pii: 10.1007/s12185-021-03251.
    PubMed         Abstract available

  20. INOUE Y, Nishimura N, Murai M, Matsumoto M, et al
    Prevention of acute graft-versus-host disease in adult T-cell leukemia-lymphoma patients who received mogamulizumab before allogeneic hematopoietic cell transplantation.
    Int J Hematol. 2021 Oct 27. pii: 10.1007/s12185-021-03250.
    PubMed         Abstract available

  21. HONDA Y, Muramatsu H, Nanjo Y, Hirabayashi S, et al
    A retrospective analysis of azacitidine treatment for juvenile myelomonocytic leukemia.
    Int J Hematol. 2021 Oct 29. pii: 10.1007/s12185-021-03248.
    PubMed         Abstract available


    J Pediatr Hematol Oncol

  22. MILLS D, Abushanab S, Elhaloul A, El Nuweiry H, et al
    Barriers to Care and Outcomes of Pediatric Acute Lymphoblastic Leukemia Treatment in the Gaza Strip.
    J Pediatr Hematol Oncol. 2021 Sep 22. pii: 00043426-900000000-96760.
    PubMed         Abstract available

  23. DAI Q, Liu R, Wang Y, Ye L, et al
    Longer Time Intervals From Symptom Onset to Diagnosis Affect the Overall Survival in Children With Acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2021 Oct 26. pii: 00043426-900000000-96722.
    PubMed         Abstract available

  24. SACHDEV M, Bansal M, Chakraborty S, Bhargava R, et al
    Seven Year Long Follow Up of Patient With Childhood Chronic Myeloid Leukemia Postsecond Haploidentical Stem Cell Transplant.
    J Pediatr Hematol Oncol. 2021;43:e1267-e1268.
    PubMed        


    Leuk Lymphoma

  25. GJAERDE LK, Rank CU, Andersen MK, Jakobsen LH, et al
    Improved survival after allogeneic transplantation for acute lymphoblastic leukemia in adults: a Danish population-based study.
    Leuk Lymphoma. 2021 Oct 21:1-10. doi: 10.1080/10428194.2021.1992620.
    PubMed         Abstract available

  26. CHEN M, Fu M, Wang A, Wu X, et al
    Cytoplasmic CD79a is a promising biomarker for B lymphoblastic leukemia follow up post CD19 CAR-T therapy.
    Leuk Lymphoma. 2021 Oct 21:1-9. doi: 10.1080/10428194.2021.1980214.
    PubMed         Abstract available

  27. TONG WH
    Comment on 'asparaginase activities during intensified treatment with pegylated E. coli asparaginase in adults with newly diagnosed acute lymphoblastic leukemia'.
    Leuk Lymphoma. 2021 Oct 22:1-2. doi: 10.1080/10428194.2021.1992760.
    PubMed        

  28. GHIUZELI CM, Styblo M, Saunders J, Calabro A, et al
    The pharmacokinetics of therapeutic arsenic trioxide in acute promyelocytic leukemia patients.
    Leuk Lymphoma. 2021 Oct 25:1-11. doi: 10.1080/10428194.2021.1978084.
    PubMed         Abstract available

  29. REX MR, Williams R, Birsoy K, Ta Llman MS, et al
    Targeting mitochondrial metabolism in acute myeloid leukemia.
    Leuk Lymphoma. 2021 Oct 27:1-8. doi: 10.1080/10428194.2021.1992759.
    PubMed         Abstract available

  30. ALDOSS I, Clark M, Marcucci G, Forman SJ, et al
    Donor derived leukemia in allogeneic transplantation.
    Leuk Lymphoma. 2021 Oct 29:1-8. doi: 10.1080/10428194.2021.1929966.
    PubMed         Abstract available


    Leuk Res

  31. MARTINEZ-VERBO L, Estrada N, Cabezon M, Palomo L, et al
    Mutational profile and relative telomere length in Chronic Myelomonocytic Leukemia subgroups according to the 2016 World Health Organization classification.
    Leuk Res. 2021;111:106726.
    PubMed        

  32. PARK H, Kim I, Kim HJ, Shin DY, et al
    Ultra-deep sequencing mutation analysis of the BCR/ABL1 kinase domain in newly diagnosed chronic myeloid leukemia patients.
    Leuk Res. 2021;111:106728.
    PubMed         Abstract available

  33. KANNAN KK, Vellanki P, Isom S, Tawfik B, et al
    Re-induction therapy in adult patients with acute myeloid leukemia with
    Leuk Res. 2021;111:106731.
    PubMed        

  34. PADMAKUMAR D, Chandraprabha VR, Gopinath P, Vimala Devi ART, et al
    A concise review on the molecular genetics of acute myeloid leukemia.
    Leuk Res. 2021;111:106727.
    PubMed         Abstract available


    Leukemia

  35. HEGDE S, Gasilina A, Wunderlich M, Lin Y, et al
    Inhibition of the RacGEF VAV3 by the small molecule IODVA1 impedes RAC signaling and overcomes resistance to tyrosine kinase inhibition in acute lymphoblastic leukemia.
    Leukemia. 2021 Oct 28. pii: 10.1038/s41375-021-01455.
    PubMed         Abstract available


    PLoS One

  36. MAHESHWARI VK, Slader C, Dani N, Gkitzia C, et al
    Enabling access to molecular monitoring for chronic myeloid leukemia patients is cost effective in China.
    PLoS One. 2021;16:e0259076.
    PubMed         Abstract available

  37. SEOMUN G, Lee J, Park J
    Exposure to extremely low-frequency magnetic fields and childhood cancer: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0251628.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: